{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:13:36Z","timestamp":1793711616092,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763796"],"award-info":[{"award-number":["2024M763796"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Medical Research Fund","award":["A2403047"],"award-info":[{"award-number":["A2403047"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402764"],"award-info":[{"award-number":["82402764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272448"],"award-info":[{"award-number":["82272448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515111078"],"award-info":[{"award-number":["2023A1515111078"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030026"],"award-info":[{"award-number":["2023A1515030026"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["RCBS20221008093103013"],"award-info":[{"award-number":["RCBS20221008093103013"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20240813150720026"],"award-info":[{"award-number":["JCYJ20240813150720026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04280-x","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:18:00Z","timestamp":1773458280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neutrophil membrane-coated and MMP2-responsive nanoparticles deliver PIM1 inhibitor to alleviate inflammatory arthritis through inhibiting Th17 cell differentiation"],"prefix":"10.1186","volume":"24","author":[{"given":"Zepeng","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"4280_CR1","doi-asserted-by":"publisher","first-page":"j3248","DOI":"10.1136\/bmj.j3248","volume":"358","author":"J Ledingham","year":"2017","unstructured":"Ledingham J, Snowden N, Ide Z. Diagnosis and early management of inflammatory arthritis. BMJ. 2017;358:j3248.","journal-title":"BMJ"},{"key":"4280_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41584-022-00761-z","volume":"18","author":"A Danve","year":"2022","unstructured":"Danve A, Deodhar A. Treatment of axial spondyloarthritis: an update. Nat Rev Rheumatol. 2022;18:205\u201316.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114499","volume":"153","author":"M Hu","year":"2025","unstructured":"Hu M, et al. T cell dysregulation in rheumatoid arthritis: recent advances and natural product interventions. Int Immunopharmacol. 2025;153:114499.","journal-title":"Int Immunopharmacol"},{"key":"4280_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213913","author":"HK Min","year":"2022","unstructured":"Min HK, Kim SH, Kim HR, Lee SH. Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis. Int J Mol Sci. 2022;23(22):13913. https:\/\/doi.org\/10.3390\/ijms232213913.","journal-title":"Int J Mol Sci"},{"key":"4280_CR5","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.4049\/jimmunol.2101025","volume":"208","author":"DE Muench","year":"2022","unstructured":"Muench DE, et al. A Pathogenic Th17\/CD38(+) Macrophage Feedback Loop Drives Inflammatory Arthritis through TNF-alpha. J Immunol. 2022;208:1315\u201328.","journal-title":"J Immunol"},{"key":"4280_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","volume":"15","author":"A Beringer","year":"2019","unstructured":"Beringer A, Miossec P. Systemic effects of IL-17 in inflammatory arthritis. Nat Rev Rheumatol. 2019;15:491\u2013501.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33502-7","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, et al. Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis. Nat Commun. 2022;13:5866.","journal-title":"Nat Commun"},{"key":"4280_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01680-25","volume":"16","author":"M Liu","year":"2025","unstructured":"Liu M, et al. PIM1 orchestrates sepsis-associated inflammatory imbalance in CD4(+) T cell subsets via cholesterol metabolism. MBio. 2025;16:e0168025.","journal-title":"MBio"},{"key":"4280_CR9","doi-asserted-by":"publisher","unstructured":"Su Z, et al. Pim1 Serves as a Therapeutic Target for Inflammatory Arthritis via Mitochondrial Metabolism and Th17 Cell Differentiation. Research (Wash D C). 2026 Feb 27;9:1137. https:\/\/doi.org\/10.34133\/research.1137","DOI":"10.34133\/research.1137"},{"key":"4280_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01898-y","volume":"22","author":"R Choudhury","year":"2024","unstructured":"Choudhury R, et al. PIM1 kinase and its diverse substrate in solid tumors. Cell Commun Signal. 2024;22:529.","journal-title":"Cell Commun Signal"},{"key":"4280_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"4280_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02049-y","volume":"9","author":"F Zhang","year":"2024","unstructured":"Zhang F, et al. Neutrophil diversity and function in health and disease. Signal Transduct Target Ther. 2024;9:343.","journal-title":"Signal Transduct Target Ther"},{"key":"4280_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","volume":"13","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018;13:1182\u201390.","journal-title":"Nat Nanotechnol"},{"key":"4280_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115051","volume":"200","author":"H Han","year":"2023","unstructured":"Han H, et al. Progress on the pathological tissue microenvironment barrier-modulated nanomedicine. Adv Drug Deliv Rev. 2023;200:115051.","journal-title":"Adv Drug Deliv Rev"},{"key":"4280_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-023-00966-w","volume":"19","author":"B Grillet","year":"2023","unstructured":"Grillet B, et al. Matrix metalloproteinases in arthritis: towards precision medicine. Nat Rev Rheumatol. 2023;19:363\u201377.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR16","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","volume":"17","author":"J Kuang","year":"2023","unstructured":"Kuang J, et al. Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy. ACS Nano. 2023;17:13333\u201347.","journal-title":"ACS Nano"},{"key":"4280_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01651-4","volume":"21","author":"L Liang","year":"2022","unstructured":"Liang L, et al. The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Mol Cancer. 2022;21:186.","journal-title":"Mol Cancer"},{"key":"4280_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/10717544.2022.2032482","volume":"29","author":"C Yu","year":"2022","unstructured":"Yu C, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29:454\u201365.","journal-title":"Drug Deliv"},{"key":"4280_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300962","volume":"12","author":"X Chen","year":"2023","unstructured":"Chen X, et al. An MMP-2 responsive nanotheranostic probe enabled synergistic therapy of rheumatoid arthritis and MR\/CT assessment of therapeutic response in situ. Adv Healthc Mater. 2023;12:e2300962.","journal-title":"Adv Healthc Mater"},{"key":"4280_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"4280_CR21","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.celrep.2020.01.022","volume":"30","author":"B Shin","year":"2020","unstructured":"Shin B, et al. Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory T cells. Cell Rep. 2020;30:1898\u2013909.","journal-title":"Cell Rep"},{"key":"4280_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05264-1","volume":"610","author":"F Baixauli","year":"2022","unstructured":"Baixauli F, et al. An LKB1-mitochondria axis controls T(H)17 effector function. Nature. 2022;610:555\u201361.","journal-title":"Nature"},{"key":"4280_CR23","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1073\/pnas.1213294110","volume":"110","author":"S Din","year":"2013","unstructured":"Din S, et al. Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation. Proc Natl Acad Sci U S A. 2013;110:5969\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4280_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04313-1","volume":"21","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS\/Cl(-) efflux signaling pathway. J Transl Med. 2023;21:452.","journal-title":"J Transl Med"},{"key":"4280_CR25","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1038\/s41388-020-1168-9","volume":"39","author":"SS Chauhan","year":"2020","unstructured":"Chauhan SS, et al. PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer. Oncogene. 2020;39:2597\u2013611.","journal-title":"Oncogene"},{"key":"4280_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41580-024-00820-1","volume":"26","author":"B Cartes-Saavedra","year":"2025","unstructured":"Cartes-Saavedra B, Ghosh A, Hajnoczky G. The roles of mitochondria in global and local intracellular calcium signalling. Nat Rev Mol Cell Biol. 2025;26:456\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4280_CR27","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/bi2018909","volume":"51","author":"B Glancy","year":"2012","unstructured":"Glancy B, Balaban RS. Role of mitochondrial Ca2\u2009+\u2009in the regulation of cellular energetics. Biochemistry. 2012;51:2959\u201373.","journal-title":"Biochemistry"},{"key":"4280_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003;426:454\u201360.","journal-title":"Nature"},{"key":"4280_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","volume":"478","author":"P Prasad","year":"2023","unstructured":"Prasad P, et al. Rheumatoid arthritis: advances in treatment strategies. Mol Cell Biochem. 2023;478:69\u201388.","journal-title":"Mol Cell Biochem"},{"key":"4280_CR30","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/rheumatology\/kez222","volume":"58","author":"E Nikiphorou","year":"2019","unstructured":"Nikiphorou E, Lempp H, Kohrt BA. Treatment failure in inflammatory arthritis: time to think about syndemics? Rheumatology. 2019;58:1526\u201333.","journal-title":"Rheumatology"},{"key":"4280_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2174\/1389201019666171226151852","volume":"18","author":"MM Luchetti","year":"2017","unstructured":"Luchetti MM, Benfaremo D, Gabrielli A. Biologics in inflammatory and immunomediated arthritis. Curr Pharm Biotechnol. 2017;18:989\u20131007.","journal-title":"Curr Pharm Biotechnol"},{"key":"4280_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/1744666X.2019.1705785","volume":"16","author":"YM Chiu","year":"2020","unstructured":"Chiu YM, Chen DY. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Rev Clin Immunol. 2020;16:207\u201328.","journal-title":"Expert Rev Clin Immunol"},{"key":"4280_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105685","volume":"91","author":"T Wirth","year":"2024","unstructured":"Wirth T, Lafforgue P, Pham T. NSAID: Current limits to prescription. Joint Bone Spine. 2024;91:105685.","journal-title":"Joint Bone Spine"},{"key":"4280_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/ard-2022-223357","volume":"82","author":"A Sepriano","year":"2023","unstructured":"Sepriano A, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2023;82:107\u201318.","journal-title":"Ann Rheum Dis"},{"key":"4280_CR35","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1021\/acsnano.3c08946","volume":"18","author":"W Zeng","year":"2024","unstructured":"Zeng W, et al. Neutrophil nanodecoys inhibit tumor metastasis by blocking the interaction between tumor cells and neutrophils. ACS Nano. 2024;18:7363\u201378.","journal-title":"ACS Nano"},{"key":"4280_CR36","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","volume":"15","author":"L Feng","year":"2021","unstructured":"Feng L, et al. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery. ACS Nano. 2021;15:2263\u201380.","journal-title":"ACS Nano"},{"key":"4280_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30:e1706759.","journal-title":"Adv Mater"},{"key":"4280_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrrheum.2016.193","volume":"13","author":"M Perretti","year":"2017","unstructured":"Perretti M, Cooper D, Dalli J, Norling LV. Immune resolution mechanisms in inflammatory arthritis. Nat Rev Rheumatol. 2017;13:87\u201399.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181:8\u201318.","journal-title":"Am J Pathol"},{"key":"4280_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ard.2011.149831","volume":"71","author":"G Xuzhu","year":"2012","unstructured":"Xuzhu G, et al. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis. 2012;71:129\u201335.","journal-title":"Ann Rheum Dis"},{"key":"4280_CR41","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jaci.2015.09.048","volume":"137","author":"J de Wit","year":"2016","unstructured":"de Wit J, et al. RORgammat inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease. J Allergy Clin Immunol. 2016;137:960\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"4280_CR42","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.41744","volume":"73","author":"NJ Maney","year":"2021","unstructured":"Maney NJ, et al. Pim kinases as therapeutic targets in early rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1820\u201330.","journal-title":"Arthritis Rheumatol"},{"key":"4280_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-024-01190-w","volume":"21","author":"JT Schnell","year":"2025","unstructured":"Schnell JT, et al. The \u201cT(reg) paradox\u201d in inflammatory arthritis. Nat Rev Rheumatol. 2025;21:9\u201321.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR44","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","volume":"13","author":"M Noack","year":"2014","unstructured":"Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev. 2014;13:668\u201377.","journal-title":"Autoimmun Rev"},{"key":"4280_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2017.10.004","volume":"267","author":"JS Park","year":"2017","unstructured":"Park JS, et al. PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells. J Control Release. 2017;267:163\u201371.","journal-title":"J Control Release"},{"key":"4280_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404510","volume":"14","author":"L Yang","year":"2025","unstructured":"Yang L, et al. Neutrophil membrane-encapsulated polymerized salicylic acid nanoparticles effectively alleviating rheumatoid arthritis by facilitating sustained release of salicylic acid into the articular cavity from chondrocytes. Adv Healthc Mater. 2025;14:e2404510.","journal-title":"Adv Healthc Mater"},{"key":"4280_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01773-x","volume":"21","author":"N Yang","year":"2023","unstructured":"Yang N, et al. Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis. J Nanobiotechnology. 2023;21:13.","journal-title":"J Nanobiotechnology"},{"key":"4280_CR48","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41416-018-0082-1","volume":"118","author":"J Cortes","year":"2018","unstructured":"Cortes J, et al. Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. Br J Cancer. 2018;118:1425\u201333.","journal-title":"Br J Cancer"},{"key":"4280_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41584-023-01009-0","volume":"19","author":"MM Jeljeli","year":"2023","unstructured":"Jeljeli MM, Adamopoulos IE. Innate immune memory in inflammatory arthritis. Nat Rev Rheumatol. 2023;19:627\u201339.","journal-title":"Nat Rev Rheumatol"},{"key":"4280_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/key261","volume":"58","author":"YJ Ha","year":"2019","unstructured":"Ha YJ, et al. PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology. 2019;58:154\u201364.","journal-title":"Rheumatology"},{"key":"4280_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443784","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, et al. PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target. Front Immunol. 2024;15:1443784.","journal-title":"Front Immunol"},{"key":"4280_CR52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/ard.2003.013243","volume":"63","author":"I Tchetverikov","year":"2004","unstructured":"Tchetverikov I, et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:881\u20133.","journal-title":"Ann Rheum Dis"},{"key":"4280_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/ar79","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, et al. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res Ther. 2000;2:145\u201353.","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04280-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:02:04Z","timestamp":1776823324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04280-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4280"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04280-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (Approval Number: 2024002664) and conducted in accordance with the guidelines for the care and use of laboratory animals. The collection of human samples and the related experiments were approved by the Ethics Committee of the Eighth Affiliated Hospital, Sun Yat-sen University (Approval Number: 2024r220).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript. The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration by another publisher.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"379"}}